FUKS; Zvi

Patent Applications and Registrations

Patent applications and USPTO patent grants for FUKS; Zvi.The latest application filed is for "perfusion modulated tumor dose sculpting with single dose radiotherapy".

Company Profile

2.4.8

FUKS; Zvi - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Perfusion Modulated Tumor Dose Sculpting With Single Dose Radiotherapy App 20220296926 - KOLESNICK; Richard ; et al.	2022-09-22
Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent Grant 11,285,137 - Kolesnick , et al. March 29, 2	2022-03-29
Methods And Compositions For Tumor Radiosensitization App 20210069330 - KOLESNICK; Richard N. ; et al.	2021-03-11
Enhancement Of Tumor Response To Chemotherapy By Activation Of The Asmase/ceramide Pathway Through Timed Administration Of A Sho App 20200188376 - Kolesnick; Richard ; et al.	2020-06-18
Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent Grant 10,413,533 - Kolesnick , et al. Sept	2019-09-17
Method And Composition To Increase Radiation-induced Tumor Therapeutic Effects App 20180015184 - Kolesnick; Richard N. ; et al.	2018-01-18
Method And Composition To Increase Radiation-induced Tumor Therapeutic Effects App 20180015183 - KOLESNICK; Richard N. ; et al.	2018-01-18
Enhancement Of Tumor Response To Chemotherapy By Activation Of The Asmase/ceramide Pathway Through Timed Administration Of A Short-acting Anti-angiogenic Agent App 20170333413 - Kolesnick; Richard ; et al.	2017-11-23
Method And Composition To Increase Radiation-induced Tumor Therapeutic Effects App 20170007718 - Kolesnick; Richard N. ; et al.	2017-01-12
Method and Composition to Increase Radiation-Induced Tumor Therapeutic Effects App 20120252883 - Kolesnick; Richard N. ; et al.	2012-10-04
Heparanase derived from human Sk-Hep-1 cell line Grant 5,362,641 - Fuks , et al. November 8, 1	1994-11-08
Method of killing sarcoma cells using fludarabine phosphate and ionizing radiation Grant 5,081,110 - Kim , et al. January 14, 1	1992-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.